Related Experiment Video
Updated: Jan 7, 2026

09:30
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.8K
Exosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis
Fernanda Santos1,2,3, Francisco A Caramelo4,5, Jorge M P Tomaz6
1Faculty of Medicine, Gynaecology Department, University of Coimbra, 3004-504 Coimbra, Portugal.
Cancers
|December 30, 2025
Summary
Extracellular vesicles show high accuracy for diagnosing cervical cancer, but their role in prognosis requires further investigation. Standardized methods and large studies are needed to confirm their clinical use.
Area of Science:
- Oncology
- Biomarkers
- Molecular Biology
Background:
- Cervical cancer presents a substantial global health challenge.
- There is a critical need for improved diagnostic and prognostic tools.
- Extracellular vesicles (EVs) are being explored as potential non-invasive biomarkers.
Purpose of the Study:
- To systematically evaluate the diagnostic and prognostic accuracy of EV-based biomarkers for cervical cancer.
- To synthesize existing evidence through meta-analysis where appropriate.
Main Methods:
- A systematic review and meta-analysis following PRISMA guidelines.
- Searched major databases (PubMed, EMBASE, Web of Science) for relevant studies.
- Included 12 articles, with 6 eligible for meta-analysis of diagnostic data.
Main Results:
- Meta-analysis showed a high diagnostic accuracy for EVs in cervical cancer (AUC = 0.87).
- Non-coding RNAs were the primary diagnostic EV biomarkers identified.
- Prognostic data were heterogeneous, precluding quantitative synthesis, but suggested correlations with outcomes.
Conclusions:
- Extracellular vesicles show significant promise as diagnostic biomarkers for cervical cancer.
- The prognostic value of EVs for cervical cancer is currently inconclusive due to heterogeneity.
- Standardization of EV isolation and large prospective studies are essential for clinical validation.

